RXi Pharmaceutical Corp. (previously Apthera, Inc.)

Category: Drugs & Pharmaceuticals

RXi Pharmaceuticals Corporation is a biotechnology company focused on discovering, developing and commercializing innovative therapies addressing major unmet medical needs using RNA-targeted and immunotherapy technologies. For more information, visit www.rxipharma.com.

In 2011, RXi acquired Apthera, Inc., an Arizona-based firm developing a pipeline of peptide-based immunotherapies for the adjuvant treatment of HER2-positive cancers.